27 Feb 2020
Inivata’s Nitzan Rosenfeld to Receive 2020 Cancer Researcher Award
Research Triangle Park, NC, USA and Cambridge, UK – Inivata, a leader in liquid biopsy, is pleased to announce that Dr. Nitzan Rosenfeld, Co-founder and Chief Scientific Officer at Inivata has been announced the winner of the 2020 Pezcoller Foundation European Association for Cancer Research (EACR) Cancer Researcher Award.
Nitzan Rosenfeld is a globally recognized expert in liquid biopsy and translational cancer research. He co-founded Inivata in 2014, and has continued to play a key role in ensuring that the company remains at the forefront of the clinical implementation of liquid biopsy. Dr. Rosenfeld also leads the Liquid Biopsies and Cancer Diagnostics academic research group at the CRUK Cambridge Institute, University of Cambridge. This group is focused on innovation in methods for analysis of circulating tumor DNA and is a pioneer in novel liquid biopsy approaches.
The Pezcoller Foundation EACR Cancer Researcher Award celebrates academic excellence and achievements in the field of cancer research and will be presented at the annual EACR 2020 Congress in Torino, Italy on 17-20 June 2020. Dr. Rosenfeld will also deliver the award lecture at the congress.
Dr. Nitzan Rosenfeld, Co-founder and Chief Scientific Officer at Inivata, commented:
“It is an honor to receive this prestigious award from an institution whose members are dedicated to conducting such important research in the fight against cancer. Liquid biopsy has the potential to transform the lives of cancer patients and their families. The recognition for having made a contribution to this field is a great encouragement, and I hope it will help inspire further research and future researchers.”